Literature DB >> 15102473

Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation.

Meggan Czapiga1, Allan D Kirk, Julie Lekstrom-Himes.   

Abstract

The danger model of immunity and tolerance holds that antigen-presenting cells (APCs), activated by stress, injury, or necrosis, but not by physiological (apoptotic) cell death, initiate adaptive immune responses. APC activation is fundamentally associated with binding of CD40 to its ligand CD154. Platelets express CD154 upon activation and are thus potential primal danger signals linking the homeostatic response to trauma to activation of the acquired immune system. Previously, we showed that platelets can undergo gradient-driven migration, or chemotaxis, toward supernatants from cells injured by repeated freeze/thaws, UV light, or ischemia/reperfusion. Herein, we demonstrate that platelet-derived CD154 induces immature dendritic cell maturation with upregulation of costimulatory molecules and IL-12p40 production. Overall, these results provide a mechanism for platelet activation of APC facilitating the induction of adaptive immunity in environments of cell injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102473     DOI: 10.1016/j.exphem.2003.11.004

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  25 in total

Review 1.  Platelet CD40L at the interface of adaptive immunity.

Authors:  Bennett D Elzey; Timothy L Ratliff; Jennifer M Sowa; Scott A Crist
Journal:  Thromb Res       Date:  2010-11-13       Impact factor: 3.944

Review 2.  The role of platelet CD154 in the modulation in adaptive immunity.

Authors:  Daniel L Sprague; Jennifer M Sowa; Bennett D Elzey; Timothy L Ratliff
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.

Authors:  He Xu; Xiaojie Zhang; Roslyn B Mannon; Allan D Kirk
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

4.  Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles.

Authors:  Daniel L Sprague; Bennett D Elzey; Scott A Crist; Thomas J Waldschmidt; Robert J Jensen; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

Review 5.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

6.  Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.

Authors:  Johnson Q Tran; Marcus O Muench; Rachael P Jackman
Journal:  Blood Adv       Date:  2020-11-10

Review 7.  Emerging roles for platelets as immune and inflammatory cells.

Authors:  Craig N Morrell; Angela A Aggrey; Lesley M Chapman; Kristina L Modjeski
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

Review 8.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

Review 9.  Platelet activation during allergic inflammation.

Authors:  Alicja Kasperska-Zajac; Barbara Rogala
Journal:  Inflammation       Date:  2007-10       Impact factor: 4.092

Review 10.  Role of platelets in neuroinflammation: a wide-angle perspective.

Authors:  Lawrence L Horstman; Wenche Jy; Yeon S Ahn; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; J Steven Alexander; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2010-02-03       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.